Novel macrocyclic amino acids that lock peptides into beta-strand conformations were developed as protease inhibitor templates, with applications in antiviral drug design against HIV and HCV.
Shape-locked drugsMacrocyclic constraints force peptides into the exact beta-strand shape needed for potent protease inhibition — precision drug engineering
What the researchers found
Novel macrocyclic amino acids that constrain peptides into beta-strand conformations were developed as protease inhibitor templates, showing application in antiviral drug design against HIV and HCV proteases.
Why it matters
Converting flexible peptides into rigid macrocyclic drugs improves their potency, selectivity, and oral bioavailability — key challenges in antiviral peptide drug development.
How the study worked
In-vitro medicinal chemistry study. Macrocyclic amino acids designed, synthesized, and incorporated into protease inhibitor scaffolds. Tested against viral proteases.
What this study cannot tell us
In-vitro design and testing. In-vivo pharmacology not demonstrated. The specific potency against viral proteases was not detailed.
How to read the evidence
Preliminary medicinal chemistry evidence with novel building block design and protease targeting, limited by early-stage development.
When this study was published
Published in 2002. Macrocyclic protease inhibitors have become mainstream in drug design, with several macrocyclic drugs now approved for HIV and HCV.
The bigger picture
Macrocyclic drug design is one of pharmaceutical chemistry's most productive strategies for creating peptide-inspired drugs. These building blocks expand the toolkit for targeting viral and other proteases.
Questions still open
- Can these macrocyclic templates achieve oral bioavailability?
- How do they compare to existing protease inhibitors?
- Could the approach be applied to other protease-driven diseases?
Common questions
What are macrocyclic drugs?
Are these used for viral infections?
Read the original research
Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity.
Journal of medicinal chemistry, 45(2), 371-81
Citation
Glenn, Matthew P; Pattenden, Leonard K; Reid, Robert C; Tyssen, David P; Tyndall, Joel D A; Birch, Christopher J; Fairlie, David P. (2002). Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity.. Journal of medicinal chemistry, 45(2), 371-81.